Sanofi’s Emerging Markets Steady Despite Venezuela Volatility

Sanofi reported steady growth in emerging markets in the second quarter despite the volatility in Venezuela and helped by continued momentum in China.

pills

Sanofi performed "very consistently" in emerging markets in the second quarter, with steady growth across geographies, according to Olivier Charmeil, the French group’s executive vice president, General Medicines & Emerging Markets, although the economic turmoil in Venezuela is expected to drag on performance this year.

Group emerging market sales were "broadly stable" versus last year, rising by 7% excluding Venezuela, CEO Olivier Brandicourt said during...

More from Business

More from Scrip